GAD1 and schizophrenia: GAD67 produces the inhibitory neurotransmitter γ-aminobutyric acid (GABA), and clinical and preclinical studies support the hypothesis that dysfunction of GABAergic inhibition plays a critical role in the pathophysiology underlying cognitive deficits in schizophrenia (Dienel and Lewis, 2019).